Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Mais filtros

Bases de dados
Tipo de documento
Intervalo de ano de publicação
1.
Curr Probl Cardiol ; 48(2): 101513, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36414041

RESUMO

Understanding health care resource utilisation and its associated costs are important for identifying areas of improvement regarding resource allocations. However, there is limited research exploring this issue in the setting of Brugada syndrome (BrS).This was a retrospective territory-wide study of BrS patients from Hong Kong. Healthcare resource utilisation for accident and emergency (A&E), inpatient and specialist outpatient attendances were analyzed over a 19-year period, with their associated costs presented in US dollars. A total of 507 BrS patients with a mean presentation age of 49.9 ± 16.3 years old were included. Of these, 384 patients displayed spontaneous type 1 electrocardiographic (ECG) Brugada pattern and 77 patients had presented with ventricular tachycardia/ventricular fibrillation (VT/VF). At the individual patient level, the median annualized costs were $110 (52-224) at the (A&E) setting, $6812 (1982-32414) at the inpatient setting and $557 (326-1001) for specialist outpatient attendances. Patients with initial VT/VF presentation had overall greater costs in inpatient ($20161 [9147-189215] vs $5290 [1613-24937],P < 0.0001) and specialist outpatient setting ($776 [438-1076] vs $542 [293-972],P = 0.015) compared to those who did not present VT. In addition, patients without Type 1 ECG pattern had greater median costs in the specialist outpatient setting ($7036 [3136-14378] vs $4895 [2409-10554],p=0.019). There is a greater health care demand in the inpatient and specialist outpatient settings for BrS patients. The most expensive attendance type was inpatient setting stay at $6812 per year. The total median annualized cost of BrS patients without VT/VF presentation was 78% lower compared to patients with VT/VF presentation.


Assuntos
Síndrome de Brugada , Humanos , Adulto , Pessoa de Meia-Idade , Idoso , Síndrome de Brugada/epidemiologia , Síndrome de Brugada/terapia , Estudos Retrospectivos , Hong Kong/epidemiologia , Fibrilação Ventricular/complicações , Arritmias Cardíacas , Eletrocardiografia , Aceitação pelo Paciente de Cuidados de Saúde
2.
Resuscitation ; 179: 152-162, 2022 10.
Artigo em Inglês | MEDLINE | ID: mdl-36031076

RESUMO

BACKGROUND: Ventricular fibrillation (VF) waveform measures reflect myocardial physiologic status. Continuous assessment of VF prognosis using such measures could guide resuscitation, but has not been possible due to CPR artifact in the ECG. A recently-validated VF measure (termed VitalityScore), which estimates the probability (0-100%) of return-of-rhythm (ROR) after shock, can assess VF during CPR, suggesting potential for continuous application during resuscitation. OBJECTIVE: We evaluated VF using VitalityScore to characterize VF prognostic status continuously during resuscitation. METHODS: We characterized VF using VitalityScore during 60 seconds of CPR and 10 seconds of subsequent pre-shock CPR interruption in patients with out-of-hospital VF arrest. VitalityScore utility was quantified using area under the receiver operating characteristic curve (AUC). VitalityScore trends over time were estimated using mixed-effects models, and associations between trends and ROR were evaluated using logistic models. A sensitivity analysis characterized VF during protracted (100-second) periods of CPR. RESULTS: We evaluated 724 VF episodes among 434 patients. After an initial decline from 0-8 seconds following VF onset, VitalityScore increased slightly during CPR from 8-60 seconds (slope: 0.18%/min). During the first 10 seconds of subsequent pre-shock CPR interruption, VitalityScore declined (slope: -14%/min). VitalityScore predicted ROR throughout CPR with AUCs 0.73-0.75. Individual VitalityScore trends during 8-60 seconds of CPR were marginally associated with subsequent ROR (adjusted odds ratio for interquartile slope change (OR) = 1.10, p = 0.21), and became significant with protracted (100 seconds) CPR duration (OR = 1.28, p = 0.006). CONCLUSION: VF prognostic status can be continuously evaluated during resuscitation, a development that could translate to patient-specific resuscitation strategies.


Assuntos
Reanimação Cardiopulmonar , Fibrilação Ventricular , Cardioversão Elétrica , Eletrocardiografia , Humanos , Prognóstico , Fibrilação Ventricular/complicações , Fibrilação Ventricular/diagnóstico , Fibrilação Ventricular/terapia
3.
Eur Heart J ; 39(21): 1981-1987, 2018 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-29566157

RESUMO

Aims: Recent studies have shown that in more than half of apparently unexplained sudden cardiac arrests (SCA), a specific aetiology can be unmasked by a careful evaluation. The characteristics and the extent to which such cases undergo a systematic thorough investigation in real-life practice are unknown. Methods and results: Data were analysed from an ongoing study, collecting all cases of out-of-hospital cardiac arrest in Paris area. Investigations performed during the index hospitalization or planned after discharge were gathered to evaluate the completeness of assessment of unexplained SCA. Between 2011 and 2016, among the 18 622 out-of-hospital cardiac arrests, 717 survivors (at hospital discharge) fulfilled the definition of cardiac SCA. Of those, 88 (12.3%) remained unexplained after electrocardiogram, echocardiography, and coronary angiography. Cardiac magnetic resonance imaging yielded the diagnosis in 25 (3.5%) cases, other investigations accounted for 14 (2.4%) additional diagnoses, and 49 (6.8%) patients were labelled as idiopathic ventricular fibrillation (IVF) (48.7 ± 15 years, 69.4% male). Among those labelled IVF, only 8 (16.3%) cases benefited from a complete workup (including pharmacological testing). Younger patients [odds ratio (OR) 6.00, 95% confidence interval (CI) 1.80-22.26] and those admitted to university centres (OR 3.60, 95% CI 1.12-12.45) were more thoroughly investigated. Genetic testing and family screening were initiated in only 9 (18.4%) and 12 (24.5%) cases, respectively. Conclusion: Our findings suggest that complete investigations are carried out in a very low proportion of unexplained SCA. Standardized, systematic approaches need to be implemented to ensure that opportunities for specific therapies and preventive strategies (including relatives) are not missed.


Assuntos
Morte Súbita Cardíaca/etiologia , Parada Cardíaca Extra-Hospitalar/etiologia , Fibrilação Ventricular/diagnóstico , Adulto , Idoso , Arritmias Cardíacas/complicações , Arritmias Cardíacas/diagnóstico , Doença do Sistema de Condução Cardíaco/complicações , Doença do Sistema de Condução Cardíaco/diagnóstico , Cardiomiopatias/complicações , Cardiomiopatias/diagnóstico , Angiografia Coronária , Doença da Artéria Coronariana/complicações , Doença da Artéria Coronariana/diagnóstico , Ecocardiografia , Eletrocardiografia , Família , Feminino , Testes Genéticos , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Sobreviventes , Fibrilação Ventricular/complicações , Fibrilação Ventricular/genética
4.
JACC Clin Electrophysiol ; 3(2): 174-183, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-29759391

RESUMO

OBJECTIVES: This study sought to assess the impact of morbid obesity on outcomes in patients with in-hospital cardiac arrest (IHCA). BACKGROUND: Obesity is associated with increased risk of out-of-hospital cardiac arrest; however, little is known about survival of morbidly obese patients with IHCA. METHODS: Using the Nationwide Inpatient Sample database from 2001 to 2008, we identified adult patients undergoing resuscitation for IHCA, including those with morbid obesity (body mass index ≥40 kg/m2) by using International Classification of Diseases 9th edition codes and clinical outcomes. Outcomes including in-hospital mortality, length of stay, and discharge dispositions were identified. Logistic regression model was used to examine the independent association of morbid obesity with mortality. RESULTS: Of 1,293,071 IHCA cases, 27,469 cases (2.1%) were morbidly obese. The overall mortality was significantly higher for the morbidly obese group than for the nonobese group experiencing in-hospital non-ventricular fibrillation (non-VF) (77% vs. 73%, respectively; p = 0.006) or VF (65% vs. 58%, respectively; p = 0.01) arrest particularly if cardiac arrest happened late (>7 days) after hospitalization. Discharge to home was significantly lower in the morbidly obese group (21% vs. 31%, respectively; p = 0.04). After we adjusted for baseline variables, morbid obesity remained an independent predictor of increased mortality. Other independent predictors of mortality were age and severe sepsis for non-VF and VF group and venous thromboembolism, cirrhosis, stroke, malignancy, and rheumatologic conditions for non-VF group. CONCLUSIONS: The overall mortality of morbidly obese patients after IHCA is worse than that for nonobese patients, especially if IHCA occurs after 7 days of hospitalization and survivors are more likely to be transferred to a skilled nursing facility.


Assuntos
Reanimação Cardiopulmonar/métodos , Parada Cardíaca/terapia , Obesidade Mórbida/complicações , Reanimação Cardiopulmonar/economia , Reanimação Cardiopulmonar/mortalidade , Feminino , Parada Cardíaca/economia , Parada Cardíaca/mortalidade , Custos Hospitalares , Humanos , Tempo de Internação/economia , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Obesidade Mórbida/economia , Obesidade Mórbida/mortalidade , Transferência de Pacientes/economia , Transferência de Pacientes/estatística & dados numéricos , Resultado do Tratamento , Estados Unidos/epidemiologia , Fibrilação Ventricular/complicações , Fibrilação Ventricular/economia , Fibrilação Ventricular/terapia
5.
Ann Epidemiol ; 26(6): 418-423.e1, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-27174737

RESUMO

PURPOSE: Out-of-hospital cardiac arrest (OHCA) is a major cause of death in the United States. How individual-level socioeconomic status (SES) influences survival is uncertain. METHODS: The investigation is a retrospective cohort study of adults who suffered OHCA and presented with a shockable rhythm in a metropolitan county from January 1, 1999-December 31, 2005. Individual-level measures of SES were obtained from vital records and surveys. SES measures included education and occupation. We used multivariable logistic regression to assess the independent association between SES measures and survival to hospital discharge. RESULTS: Of the 1390 eligible OHCA patients, 374 (27%) survived to hospital discharge. Compared to those with less than high school diploma, the multivariable-adjusted odds ratio of survival was 1.36 (95% confidence interval [CI], 0.87-2.14) for high school graduates, 1.54 (95% CI, 0.95-2.48) for those with some college, and 1.96 (95% CI, 1.17-3.27) for those with college degrees (test for trend across the categories P < .001). We did not observe an independent association between occupation and survival. CONCLUSIONS: Higher education was associated with greater survival after OHCA. This relationship was not explained by key demographic or clinical characteristics. A better understanding of the mechanism by which individual-level SES characteristics influence prognosis may provide opportunities to improve survival.


Assuntos
Escolaridade , Parada Cardíaca Extra-Hospitalar/mortalidade , Classe Social , Fibrilação Ventricular/mortalidade , Adulto , Idoso , Estudos de Coortes , Intervalos de Confiança , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Razão de Chances , Parada Cardíaca Extra-Hospitalar/etiologia , Estudos Retrospectivos , Medição de Risco , Análise de Sobrevida , Fatores de Tempo , Estados Unidos , Fibrilação Ventricular/complicações , Fibrilação Ventricular/diagnóstico
8.
Clin Cardiol ; 33(7): 396-9, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20641115

RESUMO

Many sudden cardiac deaths are due to ventricular fibrillation (VF). The use of defibrillators in hospitals or by outpatient emergency medical services (EMS) personnel can save many cardiac-arrest victims. Automated external defibrillators (AEDs) permit defibrillation by trained first responders and laypersons. AEDs are available at most public venues, and vast sums of money are spent installing and maintaining these devices. AEDs have been evaluated in a variety of public and private settings. AEDs accurately identify malignant ventricular tachyarrhythmias and frequently result in successful defibrillation. Prompt application of an AED shows a greater number of patients in VF compared with initial rhythms documented by later-arriving EMS personnel. Survival is greatest when the AED is placed within 3 to 5 minutes of a witnessed collapse. Community-based studies show increased cardiac-arrest survival when first responders are equipped with AEDs rather than waiting for paramedics to defibrillate. Wide dissemination of AEDs throughout a community increases survival from cardiac arrest when the AED is used; however, the AEDs are utilized in a very small percentage of all out-of-hospital cardiac arrests. AEDs save very few lives in residential units such as private homes or apartment complexes. AEDs are cost effective at sites where there is a high density of both potential victims and resuscitators. Placement at golf courses, health clubs, and similar venues is not cost effective; however, the visible devices are good for public awareness of the problem of sudden cardiac death and provide reassurance to patrons.


Assuntos
Serviços de Saúde Comunitária/economia , Morte Súbita Cardíaca/prevenção & controle , Desfibriladores/economia , Cardioversão Elétrica/economia , Serviços Médicos de Emergência/economia , Custos de Cuidados de Saúde , Acessibilidade aos Serviços de Saúde/economia , Saúde Pública/economia , Taquicardia Ventricular/terapia , Fibrilação Ventricular/terapia , Conscientização , Análise Custo-Benefício , Morte Súbita Cardíaca/etiologia , Cardioversão Elétrica/métodos , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Medição de Risco , Taquicardia Ventricular/complicações , Taquicardia Ventricular/economia , Taquicardia Ventricular/mortalidade , Fatores de Tempo , Resultado do Tratamento , Fibrilação Ventricular/complicações , Fibrilação Ventricular/economia , Fibrilação Ventricular/mortalidade
11.
Heart Rhythm ; 3(10): 1175-81, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17018347

RESUMO

BACKGROUND: ST segment elevation in the right precordial leads constitutes the electrocardiogram (ECG) hallmark of Brugada syndrome (BS). This pattern is variable and can be concealed, but the magnitude and the cause of ST segment fluctuations have been poorly investigated. OBJECTIVE: Our goal was to quantify ST changes and to assess rate and autonomic influences on ST level. METHODS: A 12-lead ECG was continuously recorded during 24 hours in 20 patients with BS (ages 49 +/- 12) and 10 healthy subjects (ages 32 +/- 7). Using two-dimensional binning we obtained average QRS-T complexes every 30 minutes (time bins) and at different RR intervals (rate bins) for each subject. ST level was measured at five different points located 90, 100, 110, 120, and 140 ms after Q onset (Qo). In BS patients, the highest ST elevation was measured 110 ms after Qo (Qo+110). RESULTS: ST level changes between time points were significantly greater in patients with BS compared with control subjects: on lead V2, the range of ST level at Qo+110 was 264 +/- 85 microV in BS and 91 +/- 22 microV in control subjects (P <.01). In BS, ST level decreased with heart rate acceleration: the difference in ST level at Qo+110 for RR = 900 and 600 ms was 55 +/- 53 microV (P <.01). HFnu was positively, although weakly, correlated with ST level (R(2) = 0.02, P <.01). CONCLUSIONS: ECG changes observed in patients with BS are related in part to heart rate influences on ST segment level. These spontaneous fluctuations over a 24-hour time period suggest that Holter recordings may improve the ECG diagnosis sensitivity in BS.


Assuntos
Eletrocardiografia , Parada Cardíaca/fisiopatologia , Frequência Cardíaca/fisiologia , Fibrilação Ventricular/fisiopatologia , Adulto , Idoso , Seguimentos , Parada Cardíaca/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Síndrome , Fibrilação Ventricular/complicações
13.
Med Intensiva ; 30(5): 223-31, 2006.
Artigo em Espanhol | MEDLINE | ID: mdl-16938196

RESUMO

It is considered that in Spain, every year, we have more than 24,500 out-of-hospital cardiac arrests. Around 85% of these are secondary to ventricular fibrillation, with possibility of reversion in more than 90% if defibrillation is performed in the first minute of arrhythmia. However, if we delay this defibrillation, survival possibilities disappear in a few minutes. Clinical advances in last decades have not achieved satisfactory results in the treatment of cardiac arrest as survival rates at hospital discharge do not exceed 7%. Aware of this situation, the International Scientific Societies are recommending decreasing time to defibrillation, advising, at best, a time less than five minutes between the 112-call (emergency) and adequate electric discharge. Development of automated defibrillators in Emergency Medical Systems and their use by <> of <> emergency services (police, fire fighters, etc) contribute to reach this objective. Because of this, Emergency Medical Systems are modifying their assistance strategies, to implement the early defibrillation as <>. Literature showed the effective value of automated defibrillators in the public areas but their efficiency level is less than that reached with the Emergency Services. Efficiency depends on multiple factors such as type of installation, accessibility level to emergency medical services or incidence rate of sudden cardiac arrest. Thus, their introduction should be preceded by a cost-effectiveness study. Effectiveness of automated defibrillators at home, where up to 80% of cardiac arrest are produced, has still not been evaluated. Nevertheless, in the USA, its marketing with this indication has been authorized.


Assuntos
Desfibriladores , Adulto , Pré-Escolar , Análise Custo-Benefício , Desfibriladores/economia , Desfibriladores/psicologia , Desfibriladores/estatística & dados numéricos , Diagnóstico Precoce , Auxiliares de Emergência , Primeiros Socorros/instrumentação , Parada Cardíaca/diagnóstico , Parada Cardíaca/epidemiologia , Parada Cardíaca/etiologia , Parada Cardíaca/prevenção & controle , Parada Cardíaca/terapia , Assistência Domiciliar , Humanos , Avaliação de Programas e Projetos de Saúde , Logradouros Públicos , Espanha/epidemiologia , Fatores de Tempo , Resultado do Tratamento , Fibrilação Ventricular/complicações , Fibrilação Ventricular/epidemiologia , Fibrilação Ventricular/terapia
15.
Clin Cardiol ; 29(4): 165-9, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16649726

RESUMO

BACKGROUND: In most cases, sudden cardiac death is triggered by ischemia-related ventricular tachyarrhythmias and accounts for 50% of deaths from cardiovascular disease in developed countries. Chronic elevation of indicators of coagulation activation has been found in patients with coronary heart disease, but a role of coagulation activation as a potential risk factor for ventricular fibrillation (VF) during acute myocardial infarction (MI) has not been investigated. METHODS: We enrolled 50 patients with a history of MI, of whom 26 presented with VF in the acute phase of myocardial ischemia; 24 patients had an acute MI without ventricular tachyarrhythmias. Levels of thrombin-antithrombin complexes (TAT), prothrombin fragment F1 + 2 (F1 + 2), fibrinopeptide A (FPA), plasmin-antiplasmin complexes (PAP), protein C, antithrombin, activated partial thromboplastin time (aPTT), thromboplastin time, D-Dimer, fibrinogen, and high-sensitivity C-reactive protein (hs-CRP) were measured in plasma samples of all patients. Blood collection was obtained sequentially in two separate settings. Patients were studied at a median of 351 days after the acute coronary event. RESULTS: Higher levels of TAT complexes (13.4 +/- 22.2 vs. 3.03 +/- 4.3 microg/l; p = 0.02), FPA (79.7 +/- 132.3 vs. 24.04 +/- 41.3 ng/ml; p = 0.04), and F1+2 (1.89 +/- 1.3 vs. 1.16 +/- 0.5 nmol/l; p = 0.01) were observed in patients with VF compared with patients without ventricular tachyarrhythmias during the acute phase of MI. D-Dimer levels displayed a trend without reaching statistical significance (0.69 +/- 0.48 vs. 0.48 +/- 0.24 mg/l; p = 0.06). No differences were found in hs-CRP (3.25 +/- 4.5 vs. 4.4 +/- 8.8 mg/l; p = 0.5) and fibrinogen (2.8 +/- 0.9 vs. 2.7 +/- 0.9 g/l; p = 0.6) measurements. Repeat assessment of markers of coagulation activation at a median of 847 days revealed a highly significant decrease in patients with VF. CONCLUSIONS: Markers of thrombin generation are transiently increased in patients with VF during the acute phase of MI. These findings have implications for risk assessment and genetic screening of patients prone to VF during acute myocardial ischemia.


Assuntos
Infarto do Miocárdio/sangue , Trombina/metabolismo , Fibrilação Ventricular/sangue , Antitrombina III , Antitrombinas/metabolismo , Biomarcadores/sangue , Estudos de Coortes , Feminino , Fibrinopeptídeo A/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/complicações , Fragmentos de Peptídeos/sangue , Peptídeo Hidrolases/sangue , Proteína C/metabolismo , Protrombina/metabolismo , Tempo de Trombina , Fibrilação Ventricular/complicações
16.
Circulation ; 110(25): 3866-9, 2004 Dec 21.
Artigo em Inglês | MEDLINE | ID: mdl-15611390
18.
Circulation ; 110(14): 1967-73, 2004 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-15381641

RESUMO

BACKGROUND: Early defibrillation results in higher admission rates and healthcare costs. This study determined the healthcare resources used and related medical costs after out-of-hospital cardiac arrest (OHCA) in relation to time to shock. We assessed the incremental healthcare costs per life gained from reduction in time to shock of 2, 4, and 6 minutes. METHODS AND RESULTS: Clinical and costs data of patients in witnessed OHCA with ventricular fibrillation as initial rhythm were collected. Each patient's time to shock was estimated and assigned to 1 of 3 categories: < or =7 minutes (early), 7 to 12 minutes (intermediate), and >12 minutes (late). Incremental cost-effectiveness analysis and Monte Carlo simulation compared scenarios of reduction in time to shock of 2, 4, and 6 minutes. Six-month survival was 22%. Mean prehospital, in-hospital, and posthospital costs in the first half-year after OHCA were 559 Euros, 6869 Euros and 666 Euros. Mean costs were 28,636 Euros per survivor and 2384 Euros per nonsurvivor. Among patients shocked early (n=24), 46% survived, with costs averaging 20,253 Euros. Of the intermediate group (n=149), 26% survived, with costs averaging 31,467 Euros. Among patients shocked late (n=135), 13% survived, with costs averaging 27,781 Euros. The point estimates of the incremental cost-effectiveness ratios of reduction of time to shock of 2, 4, and 6 minutes compared with baseline were 17,508 Euros, 14,303 Euros, and 12,708 Euros per life saved, respectively. CONCLUSIONS: Costs per survivor were lowest with the shortest time to shock because of shorter stay in the intensive care unit. Reducing the time to defibrillation increases the healthcare costs by an acceptable amount according to current standards and is economically attractive.


Assuntos
Desfibriladores , Cardioversão Elétrica/estatística & dados numéricos , Serviços Médicos de Emergência/economia , Custos de Cuidados de Saúde , Parada Cardíaca/economia , Fibrilação Ventricular/terapia , Idoso , Estudos de Coortes , Unidades de Cuidados Coronarianos/economia , Unidades de Cuidados Coronarianos/estatística & dados numéricos , Análise Custo-Benefício , Desfibriladores/economia , Desfibriladores/estatística & dados numéricos , Serviços Médicos de Emergência/métodos , Serviços Médicos de Emergência/estatística & dados numéricos , Feminino , Recursos em Saúde/economia , Recursos em Saúde/estatística & dados numéricos , Parada Cardíaca/etiologia , Parada Cardíaca/mortalidade , Parada Cardíaca/enfermagem , Parada Cardíaca/terapia , Custos Hospitalares , Humanos , Tempo de Internação/economia , Tábuas de Vida , Masculino , Pessoa de Meia-Idade , Países Baixos , Estudos Prospectivos , Análise de Sobrevida , Fatores de Tempo , Fibrilação Ventricular/complicações
20.
Medicina (Kaunas) ; 40(2): 121-6, 2004.
Artigo em Lituano | MEDLINE | ID: mdl-15007270

RESUMO

Despite the appearance in clinical practice of modern treatment modes as thrombolysis and percutaneous coronary intervention, in-hospital mortality from acute myocardial infarction remains an important problem. In this paper we review recently published data concerning risk stratification in the acute phase of myocardial infarction, different factors affecting the prognosis, their dynamics in the course of the disease, and inter-factor relations. We emphasize the prognostic value of three factors: heart rate variability, left ventricular dysfunction and arrhythmias. Changes in heart rate variability are discussed in association to location of myocardial infarction, patency of infarct-related artery, the chosen treatment mode and its timing. Left ventricular diastolic function and right ventricular function are shown to be predictors of morbidity and mortality after myocardial infarction besides left ventricular systolic function. We also present the latest data concerning the prognostic implication of arrhythmias, their relation to left ventricular function and autonomic nervous system balance. Atrial fibrillation and atrial flutter appear to be important factors in predicting mortality after myocardial infarction, especially in the elderly, as well as ventricular arrhythmias - sustained ventricular tachycardia and ventricular fibrillation.


Assuntos
Infarto do Miocárdio/mortalidade , Idoso , Arritmias Cardíacas/complicações , Arritmias Cardíacas/fisiopatologia , Fibrilação Atrial/complicações , Fibrilação Atrial/fisiopatologia , Flutter Atrial/complicações , Flutter Atrial/fisiopatologia , Diástole , Eletrocardiografia , Frequência Cardíaca/fisiologia , Mortalidade Hospitalar , Humanos , Infarto do Miocárdio/complicações , Infarto do Miocárdio/diagnóstico , Infarto do Miocárdio/fisiopatologia , Infarto do Miocárdio/terapia , Prognóstico , Medição de Risco , Fatores de Risco , Sístole , Taquicardia Ventricular/complicações , Taquicardia Ventricular/fisiopatologia , Fatores de Tempo , Disfunção Ventricular Esquerda/complicações , Disfunção Ventricular Esquerda/fisiopatologia , Fibrilação Ventricular/complicações , Fibrilação Ventricular/fisiopatologia , Função Ventricular Esquerda , Função Ventricular Direita
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA